PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt. Electronic address: ahmed.samir@nci.cu.edu.eg.\', \'Department of Pulmonary Medicine, Abbassia Chest Hospital, MOH, Cairo, Egypt.\', \'Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.\', \'Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.\', \'Department of Clinical and Chemical Pathology, Elsahel Teaching Hospital, MOH, Cairo, Egypt.\', \'Department of Tropical Medicine and Infectious Disease, Imbaba Fever Hospital, MOH, Cairo, Egypt.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0198-8859(21)00237-810.1016/j.humimm.2021.09.007
?:hasPublicationType
?:journal
  • Human immunology
is ?:pmid of
?:pmid
?:pmid
  • 34607724
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.856
?:rankingScore_hIndex
  • 86
is ?:relation_isRelatedTo_publication of
?:title
  • HLA-B*15 predicts survival in Egyptian patients with COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all